KBC Group NV Buys 28,419 Shares of GE HealthCare Technologies Inc. $GEHC

KBC Group NV raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 39.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 100,734 shares of the company’s stock after purchasing an additional 28,419 shares during the period. KBC Group NV’s holdings in GE HealthCare Technologies were worth $8,262,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the stock. Wedge Capital Management L L P NC acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at $26,859,000. Temasek Holdings Private Ltd acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at $99,922,000. Valicenti Advisory Services Inc. raised its stake in shares of GE HealthCare Technologies by 22.6% in the 3rd quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock valued at $5,115,000 after buying an additional 12,550 shares in the last quarter. Locust Wood Capital Advisers LLC raised its stake in shares of GE HealthCare Technologies by 7.1% in the 3rd quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock valued at $156,534,000 after buying an additional 137,992 shares in the last quarter. Finally, Nan Fung Trinity HK Ltd. acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at $23,206,000. 82.06% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Stifel Nicolaus increased their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research note on Wednesday, February 4th. Wells Fargo & Company increased their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Evercore increased their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Mizuho dropped their price objective on shares of GE HealthCare Technologies from $95.00 to $90.00 and set an “outperform” rating for the company in a research note on Monday, April 13th. Finally, BTIG Research restated a “buy” rating and issued a $91.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, March 19th. Eight research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $90.23.

GE HealthCare Technologies Trading Up 2.0%

Shares of GE HealthCare Technologies stock opened at $74.66 on Friday. The stock has a market capitalization of $34.07 billion, a P/E ratio of 16.37, a price-to-earnings-growth ratio of 1.61 and a beta of 1.17. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The company has a 50-day simple moving average of $75.45 and a 200 day simple moving average of $77.95. GE HealthCare Technologies Inc. has a 12-month low of $59.95 and a 12-month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter last year, the company posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.